City

Boston (1)

Houston (1)

Pavia (1)

Rochester (1)

Overall Status

Recruiting (2)

Not yet recruiting (1)

Phase

phase 2 (2)

n/a (1)

Sponsor

Istituti Clinici Scientifici Maugeri SpA (1)

M.D. Anderson Cancer Center (1)

Massachusetts General Hospital (1)

Collaborator

National Cancer Institute (NCI) (2)

Merck Sharp & Dohme LLC (1)

National Institutes of Health (NIH) (1)

Study Documents

Intervention Type

drug (2)

radiation (2)

other (1)

procedure (1)

Funder Type

Other (3)

Study Type

Interventional (3)

sinonasal undifferentiated carcinoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Sinonasal Undifferentiated Carcinoma Trial in Pavia (Pembrolizumab)

Not yet recruiting

Sinonasal Undifferentiated Carcinoma

Pembrolizumab

Pavia, Lombardia, Italy

Istituti Clinici Scientifici Maugeri

Jun 21, 2023

Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Nasal Cavity and Paranasal Sinus Poorly

Recruiting

Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
+6 more

Carboplatin
+7 more

Houston, Texas

M D Anderson Cancer Center

Jul 23, 2021

Adenoid Cystic Carcinoma, Squamous Cell Carcinoma, Sinonasal Carcinoma Trial in Boston, Rochester (Proton radiation therapy,

Recruiting

Adenoid Cystic Carcinoma
+8 more

Proton radiation therapy
Intensity-modulated radiotherapy

Boston, Massachusetts
+1 more

Jun 2, 2021